Benign Prostatic Hyperplasia Clinical Trials
Benign Prostatic Hyperplasia clinical trials evaluate new therapies, procedures, and monitoring approaches for benign Prostatic Hyperplasia. Corterve aggregates actively recruiting Benign Prostatic Hyperplasia studies from ClinicalTrials.gov so you can search by location and eligibility. This information is general and not medical advice — review any study with your physician before enrolling.
Recruiting Benign Prostatic Hyperplasia studies
- Post-Market Study to Assess iTind Safety in Comparison to UroLiftNCT04757116NAOlympus Corporation of the AmericasBenign Prostatic Hyperplasia (BPH)Phoenix, Arizona
- Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.NCT05148156NANorthwell HealthBenign Prostatic HyperplasiaSyosset, New York
- Ambulatory Long Length URodynamics EvaluationNCT07425015NABright UroUrologyNew Orleans, Louisiana
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)NCT06511141NAAxonics, Inc.Overactive BladderBirmingham, Alabama
- Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System RegistryNCT07538622Zenflow, Inc.BPH (Benign Prostatic Hyperplasia)Phoenix, Arizona
- Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day DischargeNCT07789041NAEndeavor HealthBPH (Benign Prostatic Hyperplasia)Glenview, Illinois
- Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported OutcomesNCT05898932Northwestern UniversityBenign Prostatic HyperplasiaGlenview, Illinois
- Sonablate HIFU International Registry for PC & BPH PatientsNCT07757490SonablateLocalized Prostate CancerIndianapolis, Indiana
- BPH Global RegistryNCT05543200Société Internationale d'UrologieBenign Prostatic HyperplasiaLos Angeles, California
- Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled TrialNCT07632742NANorthwestern UniversityEnlarged Prostate (BPH)Chicago, Illinois
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI TherapyNCT04288427NABeth Israel Deaconess Medical CenterBenign Prostatic HyperplasiaBoston, Massachusetts
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic HyperplasiaNCT06944145PHASE2Beth Israel Deaconess Medical CenterBPH (Benign Prostatic Hyperplasia)Boston, Massachusetts
Benign Prostatic Hyperplasia trials by state
Benign Prostatic Hyperplasia trials by metro
Frequently asked questions
- How do I find recruiting Benign Prostatic Hyperplasia clinical trials?
- Browse the actively recruiting Benign Prostatic Hyperplasia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Benign Prostatic Hyperplasia clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Benign Prostatic Hyperplasia clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.